About the Editors

Like the other Nature titles, Nature Biomedical Engineering has no external editorial board. Instead, all editorial decisions are made by a dedicated team of professional editors, with relevant research and editorial backgrounds. Pep, Michelle and Valeria are based in London. Filipe is based in Berlin, and Liqian in Shanghai.

Pep Pàmies, Chief Editor

Pep is leading the editorial team of Nature Biomedical Engineering. He launched the journal in 2017 after working as an editor for Nature Materials for more than 5 years, where he championed the biomaterials content, handling manuscripts and commissioning articles in a wide variety of subjects, including tissue engineering, medical imaging, regenerative medicine, cancer therapy and diagnostics. Previously, Pep conducted research in computational soft matter and biophysics at Columbia University's Chemistry Department in New York City, at the Max Planck Institute of Colloids and Interfaces in Potsdam, and at the Atomic and Molecular Physics Institute in Amsterdam. Pep obtained a PhD in Chemical Engineering in December 2003 from Rovira i Virgili University in Catalonia, Spain. Pep can be contacted at pep.pamies@nature.com (presubmission enquiries should however be submitted via the manuscript tracking system).

Michelle Korda, Senior Editor

Michelle managed advanced therapy clinical trials at University College London (UCL), and most recently ran a stratified medicine consortium and clinical trial for the treatment of rheumatoid arthritis at Queen Mary University of London. Her expertise is in advanced-therapy clinical trials and in in vivo and in vitro models for bone-defect healing. As a result of using these models to investigate the use of biomaterials and synthetic bone-graft substitutes, she became passionate about materials, particularly in relation to medical devices and tissue engineering. Michelle obtained a PhD in biomedical engineering from UCL in 2007, after investigating the ability of stem cells to regenerate bone around revision hip implants. Michelle joined Nature Biomedical Engineering in May 2016. She can be contacted at michelle.korda@nature.com (presubmission enquiries should however be submitted via the manuscript tracking system).

Filipe Almeida, Associate Editor

Filipe studied the influence of the biomechanics of the tumor microenvironment at The Wistar Institute in Philadelphia, and most recently developed composite biomaterials for the delivery of anticancer drugs at NOVA University of Lisbon. Previously, at Queen Mary University of London, where he obtained his PhD in 2015, he studied how skin cells respond to their microenvironment by using advanced microfabricated biomaterials, and developed micropatterned surfaces for high-content drug screening. Filipe’s interests span mechanobiology, biomechanics, cellular imaging, tissue engineering, nanotheranostics and cancer therapies. Filipe joined Nature Biomedical Engineering in November 2021. He can be contacted at filipe.almeida@nature.com (presubmission enquiries should however be submitted via the manuscript tracking system).

Valeria Caprettini, Associate Editor

Valeria developed nanotechnology for tissue engineering at King’s College London by leveraging nanofabrication, physics and materials science. Previously, at Istituto Italiano di Tecnologia in Genoa, Italy, where she obtained her PhD in bioengineering in 2017, she conceived and devised a microfluidic device for the spatiotemporally controlled poration of cells for the delivery of drugs, for extracellular and intracellular electrical recordings, and for spectroscopic analyses. She specialized in phenomena at interfaces between cell surfaces and nanostructures. Her expertise encompasses biomaterials, biosensing, bioimaging, drug delivery and tissue engineering. Valeria joined Nature Biomedical Engineering in August 2022. She can be contacted at valeria.caprettini@nature.com (presubmission enquiries should however be submitted via the manuscript tracking system).

Liqian Wang, Associate Editor

Liqian conducted research in DNA nanotechnology and bioelectronics at Oak Ridge National Laboratory in Tennessee, and then at the Shanghai Institute of Applied Physics. Most recently, she developed a molecular electromechanical system based on field-effect-transistor biosensors at Fudan University in Shanghai. Liqian obtained a PhD in materials science from the University of Rome Tor Vergata in April 2016, after developing electronic devices leveraging DNA self-assembly. Before joining Nature Biomedical Engineering in August 2022, Liqian handled manuscripts in the area of biomaterials as an Associate Editor for the Advanced journals (published by Wiley). She can be contacted at liqian.wang@nature.com (presubmission enquiries should however be submitted via the manuscript tracking system).